These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 32475777)

  • 1. Circulating CRP and calprotectin to diagnose CF pulmonary exacerbations.
    Jung D; Dong K; Jang J; Lam GY; Wilcox PG; Quon BS
    J Cyst Fibros; 2021 Jan; 20(1):46-49. PubMed ID: 32475777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sputum and serum calprotectin are useful biomarkers during CF exacerbation.
    Gray RD; Imrie M; Boyd AC; Porteous D; Innes JA; Greening AP
    J Cyst Fibros; 2010 May; 9(3):193-8. PubMed ID: 20299288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of C-reactive protein to predict treatment response during cystic fibrosis pulmonary exacerbations.
    Sharma A; Kirkpatrick G; Chen V; Skolnik K; Hollander Z; Wilcox P; Quon BS
    PLoS One; 2017; 12(2):e0171229. PubMed ID: 28178305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis.
    Carter SC; Franciosi AN; O'Shea KM; O'Carroll OM; Sharma A; Bell A; Keogan B; O'Reilly P; Coughlan S; Law SM; Gray RD; Hisert KB; Singh PK; Cooke G; Grogan B; De Gascun CF; Gallagher CG; Nicholson TT; Quon BS; McKone EF
    Ann Am Thorac Soc; 2022 Nov; 19(11):1818-1826. PubMed ID: 35713619
    [No Abstract]   [Full Text] [Related]  

  • 5. Utilizing centralized biorepository samples for biomarkers of cystic fibrosis lung disease severity.
    Sagel SD; Wagner BD; Ziady A; Kelley T; Clancy JP; Narvaez-Rivas M; Pilewski J; Joseloff E; Sha W; Zelnick L; Setchell KDR; Heltshe SL; Muhlebach MS
    J Cyst Fibros; 2020 Jul; 19(4):632-640. PubMed ID: 31870630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum calprotectin may reflect inflammatory activity in patients with active rheumatoid arthritis despite normal to low C-reactive protein.
    Hurnakova J; Hulejova H; Zavada J; Komarc M; Cerezo LA; Mann H; Vencovsky J; Pavelka K; Senolt L
    Clin Rheumatol; 2018 Aug; 37(8):2055-2062. PubMed ID: 29656372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated calprotectin levels reveal bowel inflammation in spondyloarthritis.
    Cypers H; Varkas G; Beeckman S; Debusschere K; Vogl T; Roth J; Drennan MB; Lavric M; Foell D; Cuvelier CA; De Vos M; Delanghe J; Van den Bosch F; Elewaut D
    Ann Rheum Dis; 2016 Jul; 75(7):1357-62. PubMed ID: 26698844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe disease in Cystic Fibrosis and fecal calprotectin levels.
    Parisi GF; Papale M; Rotolo N; Aloisio D; Tardino L; Scuderi MG; Di Benedetto V; Nenna R; Midulla F; Leonardi S
    Immunobiology; 2017 Mar; 222(3):582-586. PubMed ID: 28012584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Calprotectin Discriminates Subclinical Disease Activity from Ultrasound-Defined Remission in Patients with Rheumatoid Arthritis in Clinical Remission.
    Hurnakova J; Hulejova H; Zavada J; Komarc M; Hanova P; Klein M; Mann H; Sleglova O; Olejarova M; Forejtova S; Ruzickova O; Vencovsky J; Pavelka K; Senolt L
    PLoS One; 2016; 11(11):e0165498. PubMed ID: 27832086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin, erythrocyte sedimentation rate and C-reactive protein in acute pulmonary exacerbations of cystic fibrosis.
    Loh G; Ryaboy I; Skabelund A; French A
    Clin Respir J; 2018 Apr; 12(4):1545-1549. PubMed ID: 28884501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Profiling to Identify Blood Biomarkers Predictive of Response to Azithromycin in Children and Adolescents With Cystic Fibrosis.
    Dong K; Singh A; Ng RT; Sin DD; Tebbutt SJ; Ratjen F; Quon BS
    Chest; 2019 Oct; 156(4):667-673. PubMed ID: 31201785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of serum calprotectin in stable patients predicts exacerbation and lung function decline in cystic fibrosis.
    Reid PA; McAllister DA; Boyd AC; Innes JA; Porteous D; Greening AP; Gray RD
    Am J Respir Crit Care Med; 2015 Jan; 191(2):233-6. PubMed ID: 25590159
    [No Abstract]   [Full Text] [Related]  

  • 13. The association of fecal calprotectin and respiratory exacerbation in cystic fibrosis patients.
    Imanzadeh F; Kerami F; Hassanzad M; Hosseini A; Hajipour M; Khanbabaee G; Dara N; Khatami K; Farahbakhsh N; Sayyari A
    BMC Gastroenterol; 2022 Nov; 22(1):494. PubMed ID: 36443671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calprotectin as a marker of inflammation in patients with early rheumatoid arthritis.
    Jonsson MK; Sundlisæter NP; Nordal HH; Hammer HB; Aga AB; Olsen IC; Brokstad KA; van der Heijde D; Kvien TK; Fevang BS; Lillegraven S; Haavardsholm EA
    Ann Rheum Dis; 2017 Dec; 76(12):2031-2037. PubMed ID: 28814431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review of blood biomarkers in cystic fibrosis pulmonary exacerbations.
    Shoki AH; Mayer-Hamblett N; Wilcox PG; Sin DD; Quon BS
    Chest; 2013 Nov; 144(5):1659-1670. PubMed ID: 23868694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum Calprotectin Versus Acute-Phase Reactants in the Discrimination of Inflammatory Disease Activity in Rheumatoid Arthritis Patients Receiving Tumor Necrosis Factor Inhibitors.
    Inciarte-Mundo J; Victoria Hernández M; Ruiz-Esquide V; Raquel Cabrera-Villalba S; Ramirez J; Cuervo A; Pascal M; Yagüe J; Cañete JD; Sanmarti R
    Arthritis Care Res (Hoboken); 2016 Jul; 68(7):899-906. PubMed ID: 26841119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood mRNA biomarkers for detection of treatment response in acute pulmonary exacerbations of cystic fibrosis.
    Nick JA; Sanders LA; Ickes B; Briones NJ; Caceres SM; Malcolm KC; Brayshaw SJ; Chacon CS; Barboa CM; Jones MC; St Clair C; Taylor-Cousar JL; Nichols DP; Sagel SD; Strand M; Saavedra MT
    Thorax; 2013 Oct; 68(10):929-37. PubMed ID: 23783371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary exacerbations and acute declines in lung function in patients with cystic fibrosis.
    Wagener JS; Williams MJ; Millar SJ; Morgan WJ; Pasta DJ; Konstan MW
    J Cyst Fibros; 2018 Jul; 17(4):496-502. PubMed ID: 29685810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calprotectin in rheumatoid arthritis : association with disease activity in a cross-sectional and a longitudinal cohort.
    García-Arias M; Pascual-Salcedo D; Ramiro S; Ueberschlag ME; Jermann TM; Cara C; Martín-Mola E; Balsa A
    Mol Diagn Ther; 2013 Feb; 17(1):49-56. PubMed ID: 23329363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review on fecal calprotectin in cystic fibrosis.
    Lazzarotto ES; Vasco JFM; Führ F; Riedi CA; Filho NAR
    J Pediatr (Rio J); 2023; 99(1):4-10. PubMed ID: 35523321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.